Dallas, TX 12/17/2007 5:44:40 AM
News / Finance

Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Torrent Energy Corporation (OTCBB: TREN), Biopack Environmental Solutions Inc. (OTCBB: BPEV), Redpoint Bio Corporation (OTCBB: RPBC), HealthSport, Inc. (OTCBB: HSPO), and NACEL En ...

To sign up for our free research reports and newsletters, visit http://beaconequityresearch.com/. For more information on our research programs, please contact: Jeff Bishop at editor@beaconequityresearch.com

 

Torrent Energy Corporation (OTCBB: TREN) Up 16.13% on Friday

 

Detailed quote: http://beaconequityresearch.com/TREN

 

December 14, 2007 - Torrent Energy Reports Progress on Financing Efforts and Joint Venture Discussions

 

Torrent Energy Corporation (the "Company") (OTCBB: TREN) today announced that it is making progress on its efforts to establish additional sources of capital for the advancement of its Coos Bay coal-bed methane project. Management said the Company also is in detailed discussions with a prospective joint venture partner that has expressed interest in participating on the project.

 

John Carlson, president and CEO, said, "While the establishment of a new financing package is taking longer than anticipated, we are making meaningful progress and are optimistic that our efforts to finalize a transaction will be successful. We obviously are working to negotiate a transaction that is in the best interest of Torrent and its shareholders. While we cannot provide a definitive timetable for the completion of a funding arrangement, we will announce the results of these efforts as soon as possible."

 

Biopack Environmental Solutions Inc. (OTCBB: BPEV) Up 5.66% on Friday

 

Detailed quote: http://beaconequityresearch.com/BPEV

 

December 14, 2007 - Biopack Officially Opens Biopark

 

Biopack Environmental Solutions Inc. (OTCBB: BPEV) is pleased to announce the grand opening of its state of the art production facility known as Biopark in Jiangmen, China. The facility, situated on 6.7 acres of land, contains a 3 storey, 7800 square foot housing unit for the production staff, a 2900 square foot office and a 30,000 square foot warehouse. This facility, boasting several environmentally friendly features such as the natural convection design of the upper canopy and a unique water recycling system, will produce Biopack's 100% biodegradable product.

 

40 specially trained technicians have been newly recruited to join the Biopack team, bringing the total number of employees to over one hundred. The company anticipates that it may need to employ up to 70 additional employees as it increases production capacity over the next few months. Employee training and recruitment are ongoing.

 

Presently, Biopark houses two full production lines that have been installed and tested. This constitutes ten fully automated machine units as well as eight mixing pools for coloration of Biopack's unique 100% biodegradable food grade packaging products. Other recently installed infrastructure includes the piping and pulping system, the compressor unit and boiler. Two additional production lines are scheduled to come online in the upcoming months.

 

The company expects that initial production capacity should exceed 320 million units per year in ninety days. Based on anticipated increases in global demand of Biopack's 100% biodegradable products for 2008, Biopack expects to commence its phase II expansion. When completed, phase II should more than double Biopark's output capacity.

 

"Our new factory in Jiangmen increases our ability to competitively serve the global green packaging market. We are very pleased that we were able to complete our first showcase facility on schedule and on budget. We believe that Biopark will be a unique green showcase of the manufacturing of biodegradable products for all of Biopack's international clients," commented Gerald Lau, CEO.

 

Redpoint Bio Corporation (OTCBB: RPBC) Up 4.39% on Friday

 

Detailed quote: http://beaconequityresearch.com/RPBC

 

December 14, 2007 - Redpoint Bio Signs Research & Technology Development Agreement with The Coca-Cola Company

 

Redpoint Bio Corporation (OTCBB: RPBC), a company developing ingredients to improve the taste of pharmaceutical, food and beverage products, today announced that it has signed a research agreement with The Coca-Cola Company (NYSE: KO), the world's largest beverage company, to develop proprietary technology for use in non-alcoholic beverages.

 

Under terms of the one-year agreement, for a six month period beginning on the effective date of the agreement, Redpoint has granted Coca-Cola an exclusive right to negotiate to extend and expand the collaboration into a broader, multi-year research, development and commercialization program. For more information, see the related 8-K filing by Redpoint Bio with the Securities and Exchange Commission.

 

"We are extremely pleased to have established this new research and technology development collaboration with industry leader, The Coca-Cola Company - Redpoint Bio's second food industry collaboration signed in 2007," said Ray Salemme, Ph.D., Chief Executive Officer of Redpoint Bio. "We believe this agreement is a further endorsement of Redpoint Bio's unique capabilities for the discovery and development of beverage technology. We look forward to working with The Coca-Cola Company team."

 

Grant DuBois, Ph.D., Director, Ingredient & Product Sciences for The Coca-Cola Company, noted, "We believe that Redpoint Bio's extensive knowledge of taste science, coupled with their full suite of discovery tools, can contribute to the development of new technology for use in existing and future non-alcoholic beverages."

 

HealthSport, Inc. (OTCBB: HSPO) Up 3.33% on Friday

 

Detailed quote: http://beaconequityresearch.com/HSPO

 

December 14, 2007 - Hank Durschlag Named Interim CEO of HealthSport, Inc.

 

HealthSport, Inc. (OTCBB:HSPO), a fully integrated developer, manufacturer and marketer of branded nutritional supplements in a one-of-a-kind edible film strip delivery system, announced today that Hank Durschlag has been appointed interim CEO of the Company as it looks to expand its potential product lines from nutraceutical products to OTC prescription and veterinarian drug markets.

 

Mr. Durschlag has served on the Company's Board of Directors since September 2006 and is a co-inventor of the Enlyten SportStrips and PediaStrips. These two products were the first to deliver needed electrolytes to its users using the patent-pending oral delivery technology developed by HealthSport's wholly-owned subsidiary, Innozen, Inc. Along with patents related to thin film technology, Mr. Durschlag has co-authored patents in the fields of drug delivery and diabetes.

 

"The Company has begun to make strides in the marketing and sales of our original home grown products, Enlyten and Fix Hangover Strips, but the Company's real future is its proprietary strip technology. Our proprietary technology is capable of delivering drug actives in a faster, more efficient method than most pills and liquids, and it will become a major emphasis for us to begin developing relationships with pharmaceutical companies like the one we currently have with Shearing Plough to develop all types of prescription and non-prescription drugs through our patent pending technology," stated Hank Durschlag, CEO.

 

NACEL Energy Corporation (OTCBB: NCEN) Up 3.00% on Friday

 

Detailed quote: http://beaconequityresearch.com/NCEN

 

December 14, 2007 - NACEL Energy Targets < 20 MW WIND Energy Market

 

NACEL Energy Corporation (OTCBB: NCEN) ("NACEL Energy" or the "Company"), an emerging developer and aggregator of wind power infrastructure generating clean, renewable energy for America, today confirmed the successful formation of its WINDVEST(TM) business unit targeting the < 20 MW COMMUNITY WIND power generation market.

 

In return for an equity stake, NACEL Energy's WINDVEST(TM) business unit works to structure innovative financial partnerships with ranchers, farmers and rural electric co-operatives to improve COMMUNITY WIND power generation project economics and timelines by injecting early stage capital on attractive terms and enhancing existing Federal incentives promoting wind energy development.

 

NACEL Energy is one of the first companies in the nation developing COMMUNITY WIND -- utility-scale wind power generation -- but with a sustainable footprint and local partners. More than 90% of America's abundant wind resources occur in rural areas and COMMUNITY WIND projects can enjoy competitive advantages over larger wind energy development projects; including faster permitting times, local community support and other local and/or State incentives not available to larger projects.

 

Yesterday, the Senate fell one vote short of passing a long-term extension of the Production Tax Credit (PTC) -- legislative action the wind energy industry has long advocated. The American Wind Energy Association's Gregory Wetstone, Senior Director of Governmental and Public Affairs, stated, "Today's vote is out of step with Americans across the political spectrum who overwhelmingly support clean, home-grown renewable energy."

 

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN THIS DOCUMENT. ALL INFORMATION PROVIDED HERE IS MERELY INFORMATIONAL AND IS NOT INTENDED TO BE A RECOMMENDATION TO BUY OR SELL ANY SECURITY. YOU SHOULD CONSULT A LICENSED INVESTMENT PROFESSIONAL BEFORE MAKING ANY INVESTMENT DECISION. All material herein has been prepared by us based upon information believed to be reliable. The information contained herein is not guaranteed by us to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not always approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. We are not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed or mentioned herein. Beacon Equity Research has been compensated a total of fifteen thousand dollars by Onyx Consulting for an enrollment of HealthSport in its research program. It is the policy of Beacon Research and its affiliates to sell any stock received for services, which may cause the stock price to become depressed. Our affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. We may sell shares for less than the target price given in this opinion, or at any time following the issuance of this announcement. We will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Beacon Research and its owners undertake no obligation to update such statements.